Cargando…
Growth inhibition of human hepatocellular carcinoma cells by antagonism of the β(2) adrenergic receptor
Previous studies have shown that the activation of the β(2) adrenergic receptor (ADRB2) can stimulate several signaling pathways that promote tumor growth and metastasis. β-adrenergic antagonism may have a beneficial role in cancer treatment; however, little is known about the effect of ADRB2 inhibi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036482/ https://www.ncbi.nlm.nih.gov/pubmed/30008820 http://dx.doi.org/10.3892/ol.2018.8847 |